State Street’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $126M | Buy |
|
|||||
|
2025
Q2 | $119M | Sell |
|
|||||
|
2025
Q1 | $134M | Sell |
|
|||||
|
2024
Q4 | $121M | Buy |
|
|||||
|
2024
Q3 | $113M | Sell |
|
|||||
|
2024
Q2 | $93.5M | Sell |
|
|||||
|
2024
Q1 | $130M | Buy |
|
|||||
|
2023
Q4 | $114M | Sell |
|
|||||
|
2023
Q3 | $88.5M | Sell |
|
|||||
|
2023
Q2 | $127M | Buy |
|
|||||
|
2023
Q1 | $125M | Sell |
|
|||||
|
2022
Q4 | $146M | Buy |
|
|||||
|
2022
Q3 | $96.9M | Buy |
|
|||||
|
2022
Q2 | $38.1M | Buy |
|
|||||
|
2022
Q1 | $38.3M | Sell |
|
|||||
|
2021
Q4 | $34.2M | Sell |
|
|||||
|
2021
Q3 | $32.2M | Buy |
|
|||||
|
2021
Q2 | $34.5M | Sell |
|
|||||
|
2021
Q1 | $41.2M | Buy |
|
|||||
|
2020
Q4 | $20.4M | Sell |
|
|||||
|
2020
Q3 | $22.7M | Buy |
|
|||||
|
2020
Q2 | $30.8M | Sell |
|
|||||
|
2020
Q1 | $28.6M | Buy |
|
|||||
|
2019
Q4 | $27.8M | Buy |
|
|||||
|
2019
Q3 | $19.3M | Buy |
|
|||||
|
2019
Q2 | $6.99M | Buy |
|
|||||
|
2019
Q1 | $8.3M | Buy |
|
|||||
|
2018
Q4 | $2.99M | Buy |
|
|||||
|
2018
Q3 | $5.77M | Buy |
|
|||||
|
2018
Q2 | $4.49M | Buy |
|
|||||
|
2018
Q1 | $2.88M | Buy |
|
|||||
|
2017
Q4 | $4.45M | Buy |
|
|||||
|
2017
Q3 | $2.38M | Buy |
|
|||||
|
2017
Q2 | $2.59M | Buy |
|
|||||
|
2017
Q1 | $88K | Hold |
|
|||||
|
2016
Q4 | $47K | Hold |
|
|||||
|
2016
Q3 | $49K | Hold |
|
|||||
|
2016
Q2 | $33K | Sell |
|
|||||
|
2016
Q1 | $1.4M | Buy |
|
|||||
|
2015
Q4 | $2.78M | Buy |
|
|||||
|
2015
Q3 | $3.1M | Buy |
|
|||||
|
2015
Q2 | $2.73M | Buy |
|
|||||
|
2015
Q1 | $193K | Hold |
|
|||||
|
2014
Q4 | $133K | Sell |
|
|||||
|
2014
Q3 | $164K | Buy |
|
|||||
|
2014
Q2 | $120K | Hold |
|
|||||
|
2014
Q1 | $107K | Hold |
|
|||||
|
2013
Q4 | $92K | Buy |
|